Type of Necrosis Influences Prognosis in Hepatocellular Carcinoma After the First Transarterial Chemoembolization

10 May 2021 : Clinical Research

Zhi-Juan Wu^1BCDE, Yin-Fa Xie^2B, Xu Chang^2BCD, Lin Zhang^2AE*, Hui-Yong Wu^2B, Ji-Bing Liu^2B, Jian-Xin Zhang^2C, Peng Sun^2C

DOI: 10.12659/MSM.929884

Med Sci Monit 2021; 27:e929884

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 5 Treatment-related toxicities.

	Coagulative necrosis group (n=79)	Liquefactive necrosis group (n=92)	P value
ALT elevation	29 (36.7%)	27 (29.3%)	0.330
AST elevation	28 (35.4%)	37 (40.2%)	0.532
TB elevation	16 (20.3%)	22 (23.9%)	0.586
Nausea/vomiting	11 (13.9%)	8 (8.7%)	0.333
Abdominal pain	19 (24.1%)	17 (18.5%)	0.452
Fever	4 (5.1%)	11 (12.0%)	0.174
ALT – alanine transaminase; AST – aspartate transaminase; TB – total bilirubin. value

Back to the Article